Truist Securities Reiterates Buy on SI-BONE, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky has reiterated a Buy rating on SI-BONE (NASDAQ:SIBN) but lowered the price target from $26 to $24.

February 27, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities reaffirms a Buy rating on SI-BONE, though the price target has been reduced from $26 to $24.
While the reiteration of a Buy rating suggests continued confidence in SI-BONE's fundamentals and growth prospects, the reduction in the price target may reflect adjustments in valuation metrics or market conditions. This mixed signal could lead to neutral short-term price movement as investors weigh the positive endorsement against the lowered price expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100